Lemaitre Vascular Inc
LMAT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001158895
No open-market purchases or sales by Lemaitre Vascular Inc insiders were filed in the last 90 days; 342 institutions reported holding it in 13F filings for Q2 2026, worth $2.38B in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −9 vs. previous quarter
- 342
- 13F valueReported value at the end of Q2 2026
- $2.38B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding LMAT, Q2 2026
No superinvestor reported holding LMAT at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Lemaitre Vascular Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 11, 2026 (view filing) | May 7-8 | 4 days | LeMaitre George WChairman and CEO | SSale | −46.5K | $108.27 | −$5.03M | −3.1%1.43M after | 2 lots |
| May 11, 2026 (view filing) | May 8 | 3 days | Kamke Trent GSenior V. P., Operations | SSale | −2.93K | $107.00 | −$313.3K | −43.9%3.75K after | |
| May 11, 2026 (view filing) | May 7 | 4 days | Ross Bridget ADirector | SSale | −5.04K | $111.10 | −$560.4K | −56.1%3.94K after | |
| May 11, 2026 (view filing) | May 7 | 4 days | Jasinski Lawrence JDirector | SSale | −3.94K | $110.00 | −$433.7K | −45.5%4.71K after | |
| Mar 13, 2026 (view filing) | Mar 11 | 2 days | Kamke Trent GSenior V. P., Operations | SSale | −2.63K | $108.50 | −$284.8K | −28.2%6.68K after | |
| Mar 13, 2026 (view filing) | Mar 11 | 2 days | Roberts David BPresident and Director | SSale | −3.31K | $107.68 | −$356.6K | −18.4%14.7K after | |
| Mar 2, 2026 (view filing) | Feb 27 | 3 days | Kamke Trent GSenior V. P., Operations | SSale | −1.04K | $110.29 | −$115.1K | −13.5%6.68K after | |
| Mar 2, 2026 (view filing) | Feb 27 | 3 days | Roberts David BPresident and Director | SSale | −8.46K | $106.80 | −$904.0K | −32.0%18.0K after | |
| Mar 2, 2026 (view filing) | Feb 26-Mar 2 | 4 days | LeMaitre George WChairman and CEO | SSale | −205.9K | $107.05 | −$22.0M | −12.2%1.48M after | 2 lots10b5-1 |
| Aug 14, 2025 (view filing) | Aug 12 | 2 days | Jasinski Lawrence JDirector | SSale | −976 | $92.78 | −$90.6K | −17.0%4.77K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Lemaitre Vascular Inc at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 3,272,973 | $314.1M | 0.00% | +128,822+4.1% | Added |
| Conestoga Capital Advisors, LLC | 1,367,513 | $131.2M | 2.85% | −109,300−7.4% | Reduced |
| First Trust Advisors LP | 1,093,502 | $104.9M | 0.06% | +95,431+9.6% | Added |
| Congress Asset Management Co | 963,706 | $92.5M | 0.57% | +129,177+15.5% | Added |
| Vanguard Capital Management LLC | 953,437 | $91.5M | 0.00% | +41,379+4.5% | Added |
| State Street Corp | 901,416 | $86.5M | 0.00% | +45,632+5.3% | Added |
| Copeland Capital Management, LLC | 839,463 | $80.6M | 1.65% | −31,229−3.6% | Reduced |
| Geode Capital Management, LLC | 788,835 | $75.7M | 0.00% | +130,390+19.8% | Added |
| Price T Rowe Associates Inc | 755,142 | $72.5M | 0.01% | +460,148+156.0% | Added |
| Vanguard Portfolio Management LLC | 604,833 | $58.0M | 0.00% | +42,063+7.5% | Added |